ClinicalTrials.Veeva

Menu

Increasing Documentation and Disclosure of Sickle Cell Trait Status: An Implementation Science Approach

Nemours Children's Health logo

Nemours Children's Health

Status

Completed

Conditions

Sickle Cell Trait

Treatments

Behavioral: SCT Documentation and Disclosure Toolkit (SCT-DD)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The hemoglobinopathy newborn screen (NBS) performed on all neonates in the U.S. allows for early life-saving medical care for infants with sickle cell disease (SCD), an autosomal recessive genetic disorder. Because of its detection method, the NBS incidentally reveals hemoglobinopathy traits including sickle cell trait (SCT). In an effort to uphold the rights of the newborn to their medical data and preserve autonomy in medical decision making, pediatric and genetic society guidelines recommend disclosure and documentation of SCT results during infancy. Despite this guidance, a large guideline-to-practice gap exists: SCT status is grossly under-documented in the pediatric electronic health record and few adults report knowing their SCT status despite universal screening. We plan to evaluate the effect of a toolkit of SCT Documentation and Disclosure (SCT-DD) strategies on documentation and disclosure of SCT by pediatric primary care providers in a 2-arm randomized interrupted time series trial.

Enrollment

114 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Outpatient pediatric primary care providers within Nemours and their patients

Exclusion criteria

  • none

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

114 participants in 2 patient groups

"All-in"
Active Comparator group
Description:
In the "all-in" arm, pediatric primary care physicians receive all toolkit components at once.
Treatment:
Behavioral: SCT Documentation and Disclosure Toolkit (SCT-DD)
"Add-in"
Active Comparator group
Description:
In the "add-in" arm, pediatric primary care physicians will have sequential addition of toolkit components in 6 week increments
Treatment:
Behavioral: SCT Documentation and Disclosure Toolkit (SCT-DD)

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Corinna Schultz, MD, MSHP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems